Default | Transfer-out | Total | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Death | Total* | Failure | Total† | Death | Total* | Death = 8 months after treatment initiation | Total* | |||||
n (%) | n | p | n (%) | n | p | n (%) | n | p | n | n | p | |
All | 9 (27%, 95%CI 13–46%) | 33 | 10 (29%, 95%CI 15–47%) | 34 | 19 (36%, 95%CI 23–50%) | 53 | 15 (17%, 95%CI 10–27%) | 86 | ||||
Age, years | 0.002 | 0.85 | 0.74 | 0.100 | ||||||||
15–34 | 0 (0%) | 11 | 2 (33%) | 5 | 4 (44%) | 9 | 1 (5%) | 20 | ||||
35–54 | 1 (14%) | 7 | 4 (29%) | 14 | 6 (30%) | 20 | 4 (15%) | 27 | ||||
≥55 | 8 (53%) | 15 | 4 (27%) | 15 | 9 (37%) | 24 | 10 (26%) | 39 | ||||
Sex | 0.78 | 1.0 | 1.0 | 1.00 | ||||||||
Men | 4 (25%) | 16 | 6 (29%) | 21 | 11 (34%) | 32 | 8 (17%) | 48 | ||||
Women | 5 (29%) | 17 | 4 (31%) | 13 | 8 (38%) | 21 | 7 (18%) | 38 | ||||
Area | 0.019 | 0.47 | 0.32 | 0.074 | ||||||||
Urban | 1 (8%) | 12 | 3 (43%) | 7 | 4 (36%) | 11 | 1 (4%) | 23 | ||||
Mountainous/remote | 6 (60%) | 10 | 3 (37%) | 8 | 8 (50%) | 16 | 7 (27%) | 26 | ||||
Rural | 2 (18%) | 11 | 4 (21%) | 19 | 7 (27%) | 26 | 7 (19%) | 37 |